Ledger.Open graph →
SEC Form D · filed December 15, 2021

Phosplatin Therapeutics Inc

Offering
$37.3M
Sold
$37.3M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Elizabeth Tallett · New York, NYDirectorRosita Leong · NEW YORK, NYDirectorRobert Fallon · NEW YORK, NYExec · DirectorJohn Caouette · NEW YORK, NYDirectorPeter Espig · VANCOUVER, British Columbia, CanadaDirectorFrances Bonham · NEW YORK, NYExecNeil Sunderland · New York, NYDirectorCharles Stuckey · New York, NYDirectorMatthew Price · NEW YORK, NYDirectorRosita Leong · NEW YORK, NYDirectorRobert Fallon · NEW YORK, NYExec · DirectorJohn Caouette · NEW YORK, NYDirectorPeter Espig · NEW YORK, NYDirectorFrances Bonham · NEW YORK, NYExecNeil Sunderland · Middleburg Heights, OHDirectorCharles Stuckey · New York, NYDirectorElizabeth Tallett · New York, NYDirectorMatthew Price · NEW YORK, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗